Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma

Journal of Clinical Oncology

Volumn 32, Issue 5, 2014, Pages 409-414

  Bower, Mark ^a   Dalla Pria, Alessia ^a   Coyle, Chris ^a   Andrews, Eileen ^a   Tittle, Victoria ^a   Dhoot, Sharanjit ^a   Nelson, Mark ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; SELUMETINIB; ANTINEOPLASTIC ANTIBIOTIC; LIPOSOME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE PERCENTAGE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG RESISTANCE; EDEMA; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; ULCER; VIRUS LOAD; AIDS RELATED COMPLEX; CHI SQUARE DISTRIBUTION; DISEASE COURSE; DRUG COMBINATION; HEALTH CARE QUALITY; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TIME; TREATMENT OUTCOME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTHRACYCLINES; ANTI-HIV AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIPOSOMES; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; STANDARD OF CARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84897570098     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.51.6757     Document Type: Article

References (35)

1. International Collaboration on HIV and Cancer: Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823-1830, 2000
2. Portsmouth S, Stebbing J, Gill J, et al: A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 17:F17-F22, 2003 (Pubitemid 36951678)
3. Carrieri MP, Pradier C, Piselli P, et al: Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer 103:142-144, 2003 (Pubitemid 35424220)
4. Mocroft A, Kirk O, Clumeck N, et al: The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: The EuroSIDA Study. Cancer 100:2644-2654, 2004 (Pubitemid 38715771)
5. Engels EA, Pfeiffer RM, Goedert JJ, et al: Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 20:1645-1654, 2006 (Pubitemid 44162407)
6. Franceschi S, Maso LD, Rickenbach M, et al: Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy. Br J Cancer 99:800-804, 2008
7. Guiguet M, Boué F, Cadranel J, et al: Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): A prospective cohort study. Lancet Oncol 10:1152-1159, 2009
8. Selik RM, Byers RH Jr, Dworkin MS: Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 29:378-387, 2002 (Pubitemid 34288892)
9. Bower M, Fox P, Fife K, et al: Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. AIDS 13:2105-2111, 1999 (Pubitemid 29509588)
10. Stebbing J, Sanitt A, Nelson M, et al: A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy. Lancet 367:1495-1502, 2006
11. Holkova B, Takeshita K, Cheng DM, et al: Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol 19:3848-3851, 2001 (Pubitemid 32880063)
12. Tam HK, Zhang ZF, Jacobson LP, et al: Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 98:916-922, 2002 (Pubitemid 34286691)
13. Paparizos VA, Kyriakis KP, Papastamopoulos V, et al: Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone. J Acquir Immune Defic Syndr 30:257-258, 2002 (Pubitemid 34664423)
14. Gill J, Bourboulia D, Wilkinson J, et al: Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma. J Acquir Immune Defic Syndr 31:384-390, 2002 (Pubitemid 35397090)
15. Cattelan AM, Calabro ML, Aversa SM, et al: Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: Biological correlates of clinical outcome. Eur J Cancer 35:1809-1815, 1999 (Pubitemid 29512313)
16. Stebbing J, Gazzard B, Douek DC: Where does HIV live? N Engl J Med 350:1872-1880, 2004
17. Carcelain G, Debré P, Autran B: Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr Opin Immunol 13:483-488, 2001 (Pubitemid 32728483)
18. Carcelain G, Tubiana R, Samri A, et al: Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection. J Virol 75:234-241, 2001
19. Krown S, Metroka C, Wernz JC: Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria - AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7:1201-1207, 1989 (Pubitemid 19220121)
20. Krown SE, Testa MA, Huang J: AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification - AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 15:3085-3092, 1997 (Pubitemid 27377500)
21. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
22. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomised clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977 (Pubitemid 8018922)
23. Bower M, Nelson M, Young AM, et al: Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 23:5224-5228, 2005 (Pubitemid 46224033)
24. Bower M, Newsom-Davis T, Naresh K, et al: Clinical features and outcome in HIV-associated multicentric Castleman's disease. J Clin Oncol 29:2481-2486, 2011
25. Powles T, Robinson D, Stebbing J, et al: Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 27:884-890, 2009
26. Mosam A, Shaik F, Uldrick TS, et al: A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr 60:150-157, 2012
27. Chan J, Kravcik S, Angel JB: Development of Kaposi's sarcoma despite sustained suppression of HIV plasma viremia. J Acquir Immune Defic Syndr 22:209-210, 1999
28. Maurer T, Ponte M, Leslie K: HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med 357:1352-1353, 2007 (Pubitemid 47481472)
29. Krown SE, Lee JY, Dittmer DP: More on HIV-associated Kaposi's sarcoma. N Engl J Med 358:535-536, 2008; author reply 536
30. Stebbing J, Powles T, Bower M: AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count. AIDS 22:551-552, 2008 (Pubitemid 351317307)
31. Mani D, Neil N, Israel R, et al: A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3). J Int Assoc Physicians AIDS Care (Chic) 8:279-285, 2009
32. Crum-Cianflone NF, Hullsiek KH, Ganesan A, et al: Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic? AIDS 24:2881-2883, 2010
33. Daly ML, Fogo A, McDonald C, et al: Kaposi sarcoma: No longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm at presentation. Clin Exp Dermatol [epub ahead of print on May 21, 2013]
34. Lodi S, Guiguet M, Costagliola D, et al: Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst 102:784-792, 2010
35. Armstrong AW, Lam KH, Chase EP: Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: Incidence, survival, and geographical distribution from 1975 to 2005. Epidemiol Infect 141:200-206, 2013